背景:人乳头瘤病毒(HPV)感染是全球癌症负担的重要原因。了解影响男性临床实习生促进HPV疫苗接种意愿的因素对于中国制定有效的公共卫生策略至关重要。
方法:本研究采用分层随机抽样的方法,在2024年1月至3月期间从中国5个省抽取1,980名男性临床实习生。数据收集了参与者的人口统计学特征,HPV相关的临床经验,和知识。计划行为理论框架,包括态度,主观规范,和感知的行为控制,用于检查影响HPV疫苗推广意愿的因素。进行Logistic回归分析以确定与HPV疫苗推广意愿相关的因素。
结果:在受访者中,72.29%的人愿意鼓励其他人接种HPV疫苗。影响此意愿的重要因素包括年龄较大(OR=3.065,P≤0.001),家庭月收入较高(OR=1.449,P=0.025),参与HPV相关疾病的诊断和治疗(OR=3.458,P≤0.001),对疫苗的积极态度(OR=13.503,P=0.004),和较强的感知行为控制(OR=2.364,P=0.006)。
结论:本研究强调了实践经验和针对性教育在促进中国男性临床实习生HPV疫苗接种中的关键作用。加强这一群体的培训和教育对于改善HPV疫苗宣传和支持公共卫生工作以减少HPV相关疾病至关重要。
BACKGROUND: Human papillomavirus (HPV) infection significantly contributes to the global cancer burden. Understanding the factors influencing male clinical interns\' willingness to promote HPV vaccination is crucial for developing effective public health strategies in
China.
METHODS: This study employed a stratified random sampling method to select 1,980 male clinical interns from five provinces in
China between January and March 2024. Data were collected on participants\' demographic characteristics, HPV-related clinical experience, and knowledge. The Theory of Planned Behavior framework, encompassing attitudes, subjective norms, and perceived behavioral control, was used to examine factors influencing the willingness to promote the HPV vaccine. Logistic regression analyses were conducted to identify factors associated with the willingness to promote the HPV vaccine.
RESULTS: Among the respondents, 72.29% were willing to encourage others to receive the HPV vaccine. Significant factors influencing this willingness included older age (OR = 3.065, P ≤ 0.001), higher monthly household income (OR = 1.449, P = 0.025), participation in the diagnosis and treatment of HPV-related diseases (OR = 3.458, P ≤ 0.001), positive attitude towards the vaccine (OR = 13.503, P = 0.004), and strong perceived behavioral control (OR = 2.364, P = 0.006).
CONCLUSIONS: This study highlights the critical role of practical experience and targeted education in promoting HPV vaccination among male clinical interns in
China. Enhancing the training and education of this group is essential for improving HPV vaccine advocacy and supporting public health efforts to reduce HPV-related diseases.